---
figid: PMC8488354__fnins-15-665820-g004
figtitle: Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s
  Disease
organisms:
- Homo sapiens
- Macaca mulatta
- Saimiri sciureus
- Mus musculus
- Rattus norvegicus
- Nicotiana tabacum
- Scutellaria baicalensis
- Bos taurus
- Xenopus laevis
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Bos taurus
- Macaca mulatta
- Xenopus laevis
- Drosophila melanogaster
pmcid: PMC8488354
filename: fnins-15-665820-g004.jpg
figlink: /pmc/articles/PMC8488354/figure/F4/
number: F4
caption: Simplified diagram of the AChRs signal transduction pathways in the pre-and
  post-synaptic sites. In brain cells, intracellular AChRs – both mAChRs and nAChRs
  are located on both the surface of the plasma membrane and intracellular membranes
  of various organelles, such as endosomes, Golgi apparatus, endoplasmic reticulum,
  mitochondria, and nuclear membranes. The choline transporter-like protein1 (CHT1)
  uptake choline at the presynaptic, and the acetylcholine (ACh) transporter (AChT)
  uptake ACh at the post-synaptic site. The entrance of calcium throughout the nAChRs
  stimulates signaling factors, such as the enzymes phosphatidylinositol 3-kinase
  (PI3K)/extracellular signal-regulated protein kinase (ERK)1/2/signal transducer
  and activator of transcription 3 (STAT3). These factors prevent apoptosis and stimulate
  the expression of prosurvival genes, The signaling cascades elicited by the mAChRs
  stimulate the release of calcium from intracellular stores via the activation of
  PLC that generates the Inositol trisphosphate (IP3) that activates the IP3 receptors
  (IP3Rs) and the second messenger diacylglycerol (DAG) that stimulates the protein
  kinase C (PKC)/Raf/ERK pathway.
papertitle: Cholinergic Receptor Modulation as a Target for Preventing Dementia in
  Parkinson’s Disease.
reftext: Alexandre Iarkov, et al. Front Neurosci. 2021;15:665820.
year: '2021'
doi: 10.3389/fnins.2021.665820
journal_title: Frontiers in Neuroscience
journal_nlm_ta: Front Neurosci
publisher_name: Frontiers Media S.A.
keywords: cotinine | dementia | Parkinson’s disease | cholinergic interneurons | medium
  spiny neurons | striatum
automl_pathway: 0.9385403
figid_alias: PMC8488354__F4
figtype: Figure
redirect_from: /figures/PMC8488354__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8488354__fnins-15-665820-g004.html
  '@type': Dataset
  description: Simplified diagram of the AChRs signal transduction pathways in the
    pre-and post-synaptic sites. In brain cells, intracellular AChRs – both mAChRs
    and nAChRs are located on both the surface of the plasma membrane and intracellular
    membranes of various organelles, such as endosomes, Golgi apparatus, endoplasmic
    reticulum, mitochondria, and nuclear membranes. The choline transporter-like protein1
    (CHT1) uptake choline at the presynaptic, and the acetylcholine (ACh) transporter
    (AChT) uptake ACh at the post-synaptic site. The entrance of calcium throughout
    the nAChRs stimulates signaling factors, such as the enzymes phosphatidylinositol
    3-kinase (PI3K)/extracellular signal-regulated protein kinase (ERK)1/2/signal
    transducer and activator of transcription 3 (STAT3). These factors prevent apoptosis
    and stimulate the expression of prosurvival genes, The signaling cascades elicited
    by the mAChRs stimulate the release of calcium from intracellular stores via the
    activation of PLC that generates the Inositol trisphosphate (IP3) that activates
    the IP3 receptors (IP3Rs) and the second messenger diacylglycerol (DAG) that stimulates
    the protein kinase C (PKC)/Raf/ERK pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC5A7
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - FGFR3
  - CHAT
  - SH2D3C
  - FASTK
  - FOXD3-AS1
  - PIK3CG
  - EPHB2
  - MAPK1
  - MAPK3
  - STAT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GAA
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CHRNA4
  - ITPR1
  - ITPR3
  - Slc6a8
  - Slc5a7
  - Chat
  - Chrna2
  - Ephb1
  - Mapk3
  - Mapk1
  - Stat3
  - Gaa
  - Prkcg
  - Chrnb1
  - Chrne
  - Sh2d3c
  - Ephb2
  - Zhx2
  - Hspg2
  - Chrna7
  - Itpr1
  - slc5a7.L
  - slc5a7.S
  - fgfr3.S
  - fgfr3.L
  - mapk1.L
  - mapk1.S
  - stat3.L
  - raf1.S
  - hspg2.L
  - chrna4.L
  - chrna4.S
  - itpr1.S
  - itpr1.L
  - Cht10
  - achi
  - emc
  - ChAT
  - nAChRbeta1
  - nAChRalpha1
  - Erk7
  - rl
  - Raf
  - slow
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Galphas
  - tRNA:Glu-TTC-1-5
  - tRNA:Glu-TTC-1-3
  - tRNA:Glu-TTC-1-2
  - tRNA:Glu-TTC-1-6
  - tRNA:Glu-TTC-1-1
  - tRNA:Glu-TTC-1-4
  - norpA
  - sl
  - Plc21C
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - mAChR-A
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRalpha4
  - nAChRalpha2
  - nAChRbeta2
  - Itpr
---
